Introduction to Review Series on Pulmonary Vascular Disease and Right Ventricular Heart Failure.
Introduction to Review Series on Pulmonary Vascular Disease and Right Ventricular Heart Failure.
复制标题
DOI:
10.1161/circresaha.122.321168
复制
发表时间:
2022-04-29
影响因子:
20.1
通讯作者:
Hemnes, Anna R.
中科院分区:
文献类型:
--
作者:
Brittain, Evan L.;Hemnes, Anna R.
The history of pulmonary hypertension is a short one to date—not even 75 years since a living human was found to have this condition by Dresdale et al1 in 1951. This seminal diagnosis was the culmination of hundreds of years of physiological research in the pulmonary circulation. Drawing on the work of early pioneers such as Ibn Al-Nafis and others, Sir William Harvey in “Du Moto Cordis et Sanguinis” in 1628 explained the elegant simplicity of blood circulation with a separate circulation in the lungs and its own pump, the right ventricle (RV). Animal studies in the late 1800s demonstrated the feasibility of left and right heart catheterization, 2 but it was not until Dr Werner Forssmann3 performed a right heart catheterization on himself using a urologic catheter in 1922 that it would be even possible to measure the pressure in the pulmonary circulation. The use of this groundbreaking procedure allowed others such as Drs Andre Cournand and Dickson Richards, with whom Forssmann later shared the Nobel Prize, to make seminal discoveries on the function of the cardiopulmonary unit. 4 Nearly 30 years later, Dresdale et al described a patient with pulmonary hypertension (PH).The clinical report by Dresdale et al was the beginning of a field of study that is the subject of this review series in Circulation Research: Pulmonary Hypertension. An early understanding of the drivers of pulmonary hypertension was penned by Dr Paul Wood, 5 who considered the major physiological disorders of the pulmonary circulation to be (1) passive pulmonary hypertension,(2) obliterative pulmonary hypertension,(3) hyperkinetic pulmonary hypertension, and (4) vasoconstrictive pulmonary